Paul Thomas's Net Worth
$39.8 Million
Who is Paul Thomas?
Paul Thomas has an estimated net worth of $39.8 Million. This is based on reported shares across multiple companies, which include ABIOMED INC, Axogen, Inc., Roka BioScience, Inc., SURGALIGN HOLDINGS, INC., KINETIC CONCEPTS INC /TX/, RTI SURGICAL, INC., AVANIR PHARMACEUTICALS, Aegerion Pharmaceuticals, Inc., ORTHOVITA INC, and LIFECELL CORP.
SEC CIK
Paul Thomas's CIK is 0001166776
Past Insider Trading and Trends
2005 was Paul Thomas's most active year for acquiring shares with 25 total transactions. Paul Thomas's most active month to acquire stocks was the month of December. 2005 was Paul Thomas's most active year for disposing of shares, totalling 36 transactions. Paul Thomas's most active month to dispose stocks was the month of July. 2005 saw Paul Thomas paying a total of $2,446,968.92 for 956,352 shares, this is the most they've acquired in one year. In 2008 Paul Thomas cashed out on 612,907 shares for a total of $17,567,070.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABIOMED INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.36K |
—
|
—
|
0
|
Dec 22
| |||
Form 4
| -13.59% | -1.00K |
$379.38 | -$379,380.00 | 6.36K |
Scheduled
|
Nov 1
| ||
Form 4
| +6.50% | 449 |
$293.34 | -$68,054.88 | 7.36K |
Aug 10 - Aug 11
| |||
Form 4
| -8.76% | -663.00 |
$330.77 | -$219,300.51 | 6.91K |
Scheduled
|
Aug 18
| ||
Form 4
| +5.28% | 380 |
$319.88 | -$78,370.60 | 7.57K |
Aug 11 - Aug 12
| |||
Form 4
| +10.12% | 661 |
—
|
—
| 7.19K |
Aug 12
| |||
Form 4
| -26.79% | -2.39K |
$305.30 | -$729,662.20 | 6.53K |
Scheduled
|
Aug 7 - Aug 10
| ||
Form 4
| -18.32% | -2.00K |
$151.78 | -$303,561.20 | 8.92K |
Scheduled
|
Mar 2
| ||
Form 4
| -15.48% | -2.00K |
$181.13 | -$362,250.40 | 10.92K |
Scheduled
|
Feb 10
| ||
Form 4
| +6.67% | 808 |
$189.93 | -$46,532.85 | 12.92K |
Aug 7 - Aug 8
| |||
Form 4
| -0.49% | -60.00 |
$376.01 | -$222,221.91 | 12.11K |
Aug 8
| |||
Form 4
| -45.10% | -10.00K |
$154.71 | -$1,547,075.00 | 12.17K |
Scheduled
|
Aug 15
| ||
Form 4
| -5.35% | -1.25K |
$151.37 | -$189,817.98 | 22.17K |
Aug 13
| |||
Form 4
| +2.16% | 496 |
$155.87 | -$122,669.69 | 23.43K |
Aug 9
| |||
Form 4
| +7.61% | 1.62K |
—
|
—
| 22.93K |
Aug 1 - Aug 9
| |||
Form 4
|
—
|
0
|
$68.80 | -$997,147.00 | 21.31K |
Aug 1
| |||
Form 4
|
—
|
0
|
$51.53 | -$654,175.83 | 21.31K |
Scheduled
|
May 5
| ||
Form 4
| -5.60% | -1.26K |
$105.75 | -$133,773.75 | 21.31K |
Aug 14
| |||
Form 4
| +13.21% | 2.63K |
$100.65 | -$127,322.25 | 22.58K |
Aug 12 - Aug 13
| |||
Form 4
| -4.19% | -872.00 |
$95.68 | -$83,432.96 | 19.94K |
Aug 8
| |||
Form 4
|
—
|
0
|
$50.83 | -$643,598.76 | 20.81K |
Aug 6
| |||
Form 4
| +59.21% | 7.74K |
—
|
—
| 20.81K |
Aug 13
| |||
Form 4
| +145.13% | 7.74K |
—
|
—
| 13.07K |
Aug 14
| |||
Form 4
|
∞
| 5.33K |
—
|
—
| 5.33K |
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axogen, Inc. (AXGN) Snapshot price: $9.655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
| +212.75% | 6.46K |
—
|
—
| 9.49K |
Jun 1
| |||
Form 4
|
∞
| 3.04K |
—
|
—
| 3.04K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roka BioScience, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.12% | 7.14K |
$7.00 | $50,001.00 | 85.49K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SURGALIGN HOLDINGS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +397.31% | 22.86K |
—
|
—
| 28.61K |
Aug 15
| |||
Form 4/A
| +71.96% | 72.25K |
—
|
—
| 172.67K |
May 7
| |||
Form 4
| +57.56% | 57.8K |
—
|
—
| 158.22K |
May 7
| |||
Form 4
| +32.61% | 24.69K |
—
|
—
| 100.42K |
Feb 26
| |||
Form 4
|
∞
| 75.72K |
—
|
—
| 75.72K |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KINETIC CONCEPTS INC /TX/ No price found
President, LifeCell Corp.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.00K |
—
|
—
|
0
|
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||